5 Questions CFOs Should Ask Before Buying AI RCM Software
Evaluate AI RCM investments with defined metrics, payer-specific evidence, realistic cash-flow assumptions, exception handling, and an accountable pilot.
A useful AI revenue cycle management evaluation ends with a decision you can defend: which workflow to test, how to measure it, what it costs, and when to stop. A product demonstration alone cannot answer those questions.
This guide proposes five finance-focused questions for an RCM pilot. The recommendations are an evaluation framework, not an industry benchmark or a claim about QuickIntell customer performance.
1. What exactly does the reported improvement measure?
Ask the vendor to write down the numerator, denominator, observation period, exclusions, and data source for every headline metric. Keep submission acceptance, payer adjudication, and cash collection separate in your evaluation. A receipt acknowledging submission should not be counted as collected revenue.
Request a result sheet that includes:
- The workflow being evaluated and the claims or encounters eligible for it.
- Baseline and pilot periods, with payer, specialty, and volume differences visible.
- Counts as well as percentages, including missing outcomes and manual interventions.
- A reconciliation from the operational result to the financial benefit being claimed.
Agree on the definitions before the pilot starts. If a metric changes later, retain the original calculation and explain the difference. Do not count a modeled denial prevention as a demonstrated payment outcome.
2. Does the evidence match our payer and workflow mix?
Choose a bounded workflow and list the relevant plans, transaction types, and exceptions. Ask for a coverage matrix showing what is available, what requires configuration, and what remains manual. A national payer name alone is not a useful test boundary.
For each included workflow, request a demonstration using approved test data. Trace an input to its result and then to the record your staff would use. Include a missing-information case and an unsupported-plan case, not just a successful submission.
Document who maintains policy references, how changes are detected, and how the team handles an unavailable source. Treat “not yet demonstrated” as an open item rather than converting it into a positive score.
3. When does the investment produce net value?
Build the cash-flow model from your own assumptions. Include implementation fees, recurring charges, interface costs, internal staff time, training, and parallel operation. Separate savings that reduce expenditure from time that is freed for other work.
Use at least a base case and a downside case. Make deployment timing, eligible volume, adoption, and collection timing explicit. Do not annualize a short favorable period without showing that assumption.
The ROI planning calculator can help organize a scenario. Its outputs are estimates from the entered assumptions, not validated specialty benchmarks or guaranteed savings. Reconcile any proposed benefit against your finance team's model before making an investment decision.
4. What happens when the system cannot complete the task?
Ask the team to demonstrate an exception from discovery to resolution. Identify who receives the task, what context is preserved, and how it becomes visible if nobody acts. Include an integration outage and a correction to a previously accepted result.
Set pilot acceptance criteria for both completed work and unresolved work. A faster happy path is insufficient if staff cannot find the exceptions. Record who can pause automation, who authorizes a restart, and how affected records are identified.
5. Who owns the decision, the data, and the exit?
Assign finance, operations, security, and compliance owners before production data is introduced. Request the actual agreement, data-flow description, retention terms, and security evidence for the proposed deployment. Ask what can be exported and what assistance is available at termination.
HHS explains that a cloud provider handling electronic protected health information on a regulated entity's behalf can be a business associate even when it cannot decrypt the data. A BAA does not replace the organization's own risk analysis or other HIPAA obligations. Use that guidance with your privacy and legal teams; this article does not certify any vendor's compliance. HHS cloud-computing guidance.
Turn the answers into a pilot decision
Before signing off, put the scope, baseline, success criteria, stop conditions, owners, and evidence location on one page. Set a review date based on when the pilot can produce meaningful outcomes, not a generic promise of payback in a fixed number of days.
For the broader procurement framework, use the vendor evaluation checklist and its linked scorecard. Keep one scoring framework; use these five questions to strengthen its financial evidence rather than introducing conflicting weights.
Public-reference check: September 6, 2026. This is operational planning guidance, not financial, clinical, or legal advice. No customer outcome, certification, or credentialed review is asserted.